NCT07332455: First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 54 planned
- Started
- 10 Feb 2026
- Primary completion
- 24 Mar 2028
- Arms
- Participants receiving GSK5471713
- Results
- None posted
- 12 Jan 2026: Trial registered
- 10 Feb 2026: Trial started